UK's Oxford Biomedica falls as takeover talks with EQT end

Oxford BioMedica

25/02/2026 13:01

** Shares of British cell and gene therapy manufacturer Oxford Biomedica OXB.L down as much as 9.5% at 618p

** Co says private equity firm EQT EQTAB.ST says it has dropped its takeover bid for Oxford, after board rejects four proposals

** OXB says proposals undervalue company

** YTD, shares up 5.02%

 (Reporting by Tuhina in Bengaluru)

 ((tuhina@thomsonreuters.com))